Strattera and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Oxycodone (oxycodone hydrochloride). Common drug interactions include dyslipidaemia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Oxycodone. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

78 people who take Strattera and Oxycodone together, and have interactions are studied.

Strattera and Oxycodone drug interactions.

What are the common drug interactions of Strattera and Oxycodone, by gender? *:

female:

  1. Dyslipidaemia (abnormal amount of lipids)
  2. Hyperlipidaemia (presence of excess lipids in the blood)
  3. Hypertension (high blood pressure)
  4. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  5. Hypokalaemia (low potassium)
  6. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  7. Kidney infection
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Nephrocalcinosis (a condition in which calcium levels in the kidneys are increased)
  10. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)

male:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Diarrhoea
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Fall
  6. Feeding disorder (when children refuse to eat certain food groups)
  7. Gastric disorder (disease of stomach)
  8. Hand fracture
  9. Hyperphagia (an abnormal appetite for food)
  10. Hypertension (high blood pressure)

What are the common drug interactions of Strattera and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Abnormal behaviour
  3. Body temperature increased
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Confusional state
  6. Constipation
  7. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  8. Dyslogia (impaired ability to express ideas verbally)
  9. Hallucination (an experience involving the perception of something not present)
  10. Hypoxia (low oxygen in tissues)

30-39:

  1. Hand fracture
  2. Nausea (feeling of having an urge to vomit)
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Dyspepsia (indigestion)
  6. Abdominal pain lower
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Arthralgia (joint pain)
  10. Blood creatinine increased

40-49:

  1. Death
  2. Breast cancer
  3. Cardiac failure
  4. Dyslipidaemia (abnormal amount of lipids)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Hypertension (high blood pressure)
  7. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  8. Hypokalaemia (low potassium)
  9. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  10. Kidney infection

50-59:

  1. Weight decreased
  2. Abdominal discomfort
  3. Abdominal pain upper
  4. Arthralgia (joint pain)
  5. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
  6. Bedridden
  7. Colitis (inflammation of colon)
  8. Diarrhoea
  9. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  10. Feeding disorder (when children refuse to eat certain food groups)

60+:

  1. Chronic kidney disease
  2. Dizziness
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Death
  5. Drug ineffective
  6. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Heart valve replacement
  9. Hepatitis b
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 19 people, 24.36%
  2. Depression: 15 people, 19.23%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 15.38%
  4. High Blood Pressure: 11 people, 14.10%
  5. Muscle Spasms (muscle contraction): 9 people, 11.54%
  6. Joint Pain: 8 people, 10.26%
  7. Hypersensitivity: 8 people, 10.26%
  8. Inflammatory Bowel Disease: 7 people, 8.97%
  9. Incontinence (lack of moderation or self-control): 7 people, 8.97%
  10. High Blood Cholesterol: 7 people, 8.97%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Strattera and Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Strattera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride and oxycodone hydrochloride (the active ingredients of Strattera and Oxycodone, respectively), and Strattera and Oxycodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: